Forus is a Healthtech company. It has raised $160M in total funding. Latest round: Series B. Backed by Thrive Capital, General Catalyst, Accel.
Forus funding overview
Forus is a Healthtech company. Forus has raised $160M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in May 2026. The round record for Forus runs through 2026; nothing later has been disclosed. Investors on record include Thrive Capital, General Catalyst, Accel, Bain Capital Ventures, Redpoint, BoxGroup and 1 others. 7 distinct backers are named across the disclosed rounds.
Forus at a glance
Total raised
$160M
Latest round
Series B
Latest round date
May 2026
Industry
Healthtech
Notable investors
Thrive Capital, General Catalyst, Accel, Bain Capital Ventures, Redpoint, BoxGroup, Pear VC
Frequently asked about Forus funding
How much has Forus raised?
Forus has raised $160M in total disclosed funding across the rounds on record.
Who has invested in Forus?
Thrive Capital, General Catalyst, Accel, Bain Capital Ventures, Redpoint, BoxGroup are named among the investors backing Forus.
What was the latest Forus funding round?
The most recent disclosed round is a Series B, announced in May 2026.
Where is Forus based?
No headquarters location is disclosed for Forus.
What sector does Forus operate in?
Forus is tracked under Healthtech, with $160M in disclosed funding.
When did Forus last raise?
The last disclosed Forus round closed in May 2026 at Series B.
Totals shown for Forus aggregate every disclosed round on file. To see how that compares, browse the Healthtech companies and the investors behind them below.
